S. 4152 · 117th Congress · Senate

A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Active· Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced
May 5, 22
Passed Senate
Pending
Passed House
Pending
Sent to President
Pending
Signed into Law
Pending

No roll call votes have been recorded for this bill.